Search research articles
Contact Us
Filters
Showing results (101-110 of 122) with videos related to
Page
of 13
Sort By:
Journal for Immunotherapy of Cancer
|
September 9, 2020
Cell-based artificial APC resistant to lentiviral transduction for efficient generation of CAR-T cells from various cell sources
Andrea Schmidts, Leah C Marsh, Ambike A Srivastava, et al.
Nature Biotechnology
|
July 24, 2019
CAR-T cells secreting BiTEs circumvent antigen escape without detectable toxicity
Bryan D Choi, Xiaoling Yu, Ana P Castano, et al.
Nature Biomedical Engineering
|
May 29, 2025
ROCK-dependent mechanotransduction of macroscale forces drives fibrosis in degenerative spinal disease
Muhamed Hadzipasic, Margaret S Sten, Elie Massaad, et al.
Journal of Hematology & Oncology
|
January 14, 2026
Patterns, risk factors and management of CD19-directed chimeric antigen receptor T-cell therapy failure in CNS lymphoma
Leon D Kaulen, Philipp Karschnia, Sofia Doubrovinskaia, et al.
Blood Advances
|
November 8, 2019
Rational design of a trimeric APRIL-based CAR-binding domain enables efficient targeting of multiple myeloma
Andrea Schmidts, Maria Ormhøj, Bryan D Choi, et al.
Cancer Immunology Research
|
June 2, 2025
Secretion of a VEGF-Blocking scFv Enhances CAR T-cell Potency
Valentina M Supper, Hannah Donner, Filippo Birocchi, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
August 7, 2020
A Distinct Transcriptional Program in Human CAR T Cells Bearing the 4-1BB Signaling Domain Revealed by scRNA-Seq
Angela C Boroughs, Rebecca C Larson, Nemanja D Marjanovic, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 29, 2018
A Rationally Designed Fully Human EGFRvIII:CD3-Targeted Bispecific Antibody Redirects Human T Cells to Treat Patient-derived Intracerebral Malignant Glioma
Patrick C Gedeon, Teilo H Schaller, Satish K Chitneni, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 24, 2019
Chimeric Antigen Receptor T Cells Targeting CD79b Show Efficacy in Lymphoma with or without Cotargeting CD19
Maria Ormhøj, Irene Scarfò, Maria L Cabral, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 15, 2024
Correction: Chimeric Antigen Receptor T Cells Targeting CD79b Show Efficacy in Lymphoma with or without Cotargeting CD19
Maria Ormhøj, Irene Scarfò, Maria L Cabral, et al.
Page
of 13
Search research articles
Search
Showing results (101-110 of 122) with videos related to
Sort By:
Page
of 13
Journal for Immunotherapy of Cancer
|
September 9, 2020
Cell-based artificial APC resistant to lentiviral transduction for efficient generation of CAR-T cells from various cell sources
Andrea Schmidts, Leah C Marsh, Ambike A Srivastava, et al.
Nature Biotechnology
|
July 24, 2019
CAR-T cells secreting BiTEs circumvent antigen escape without detectable toxicity
Bryan D Choi, Xiaoling Yu, Ana P Castano, et al.
Nature Biomedical Engineering
|
May 29, 2025
ROCK-dependent mechanotransduction of macroscale forces drives fibrosis in degenerative spinal disease
Muhamed Hadzipasic, Margaret S Sten, Elie Massaad, et al.
Journal of Hematology & Oncology
|
January 14, 2026
Patterns, risk factors and management of CD19-directed chimeric antigen receptor T-cell therapy failure in CNS lymphoma
Leon D Kaulen, Philipp Karschnia, Sofia Doubrovinskaia, et al.
Blood Advances
|
November 8, 2019
Rational design of a trimeric APRIL-based CAR-binding domain enables efficient targeting of multiple myeloma
Andrea Schmidts, Maria Ormhøj, Bryan D Choi, et al.
Cancer Immunology Research
|
June 2, 2025
Secretion of a VEGF-Blocking scFv Enhances CAR T-cell Potency
Valentina M Supper, Hannah Donner, Filippo Birocchi, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
August 7, 2020
A Distinct Transcriptional Program in Human CAR T Cells Bearing the 4-1BB Signaling Domain Revealed by scRNA-Seq
Angela C Boroughs, Rebecca C Larson, Nemanja D Marjanovic, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 29, 2018
A Rationally Designed Fully Human EGFRvIII:CD3-Targeted Bispecific Antibody Redirects Human T Cells to Treat Patient-derived Intracerebral Malignant Glioma
Patrick C Gedeon, Teilo H Schaller, Satish K Chitneni, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 24, 2019
Chimeric Antigen Receptor T Cells Targeting CD79b Show Efficacy in Lymphoma with or without Cotargeting CD19
Maria Ormhøj, Irene Scarfò, Maria L Cabral, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 15, 2024
Correction: Chimeric Antigen Receptor T Cells Targeting CD79b Show Efficacy in Lymphoma with or without Cotargeting CD19
Maria Ormhøj, Irene Scarfò, Maria L Cabral, et al.
Page
of 13